These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

81 related articles for article (PubMed ID: 2839891)

  • 41. [Low molecular weight heparins].
    Kher A; Bara L; Samama M
    Pathol Biol (Paris); 1986 Jan; 34(1):61-9. PubMed ID: 3517772
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Antithrombotic actions and pharmacokinetics of heparin fractions and fragments.
    Fareed J; Kumar A; Walenga JM; Emanuele RM; Williamson K; Hoppensteadt D
    Nouv Rev Fr Hematol (1978); 1984; 26(4):267-75. PubMed ID: 6473096
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Glycosaminoglycans and the control of cell surface proteinase activity.
    Long WF; Williamson FB
    Med Hypotheses; 1983 Jul; 11(3):285-308. PubMed ID: 6358810
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Heparin - plasmaprotein interactions. Current status.
    Steinbuch M
    Rev Fr Transfus Immunohematol; 1982 Apr; 25(2):217-38. PubMed ID: 7048490
    [No Abstract]   [Full Text] [Related]  

  • 45. Heparins--anionic polyelectrolyte drugs.
    Jaques LB
    Pharmacol Rev; 1979 Jun; 31(2):99-166. PubMed ID: 399524
    [No Abstract]   [Full Text] [Related]  

  • 46. Some recent developments in the pharmacology of heparin.
    Coon WW
    J Clin Pharmacol; 1979 Jul; 19(7):337-49. PubMed ID: 479378
    [No Abstract]   [Full Text] [Related]  

  • 47. Low-molecular-weight heparins. Pharmacology, in vitro and ex vivo effects and clinical results. 4th Congress on Thrombosis and Haemostasis Research. Düsseldorf, October 12-16, 1986. Proceedings.
    Haemostasis; 1988; 18 Suppl 3():1-88. PubMed ID: 2840369
    [No Abstract]   [Full Text] [Related]  

  • 48. SYMPOSIUM ON HEPARIN. INTRODUCTION.
    GRIFFITH GC; SILVERGLADE A
    Am J Cardiol; 1964 Jul; 14():1-2. PubMed ID: 14176884
    [No Abstract]   [Full Text] [Related]  

  • 49. A comparison of three chemical methods of assay of heparin [proceedings].
    Anderson W; Harthill JE; Pryce-Jones RH
    J Pharm Pharmacol; 1979 Dec; 31 Suppl():93P. PubMed ID: 42773
    [No Abstract]   [Full Text] [Related]  

  • 50. A simple method for the determination of heparin content in heparin--sepharose.
    Varshavskaya MY; Klibanov AL; Goldmacher VS; Torchilin VP
    Anal Biochem; 1979 Jun; 95(2):449-51. PubMed ID: 453530
    [No Abstract]   [Full Text] [Related]  

  • 51. [The heparins: structure and pharmacology].
    Choay J
    Rev Prat; 1988 May; 38(15):917-24. PubMed ID: 2839891
    [No Abstract]   [Full Text] [Related]  

  • 52. Chemistry of heparin and low molecular weight heparin.
    Nielsen JI; Ostergaard P
    Acta Chir Scand Suppl; 1988; 543():52-6. PubMed ID: 2847458
    [No Abstract]   [Full Text] [Related]  

  • 53. Effects of calcium ions on the interactions between antithrombin and factor Xa mediated by variously sulfated, semisynthetic low-molecular-weight heparins.
    Sissi C; Lucatello L; Naggi A; Torri G; Palumbo M
    Semin Thromb Hemost; 2002 Aug; 28(4):355-60. PubMed ID: 12244482
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [New data on heparin (a review)].
    Bychkov SM
    Vopr Med Khim; 1981; 27(6):726-36. PubMed ID: 7039095
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacology of the low-molecular-weight heparins.
    Fareed J; Hoppensteadt DA
    Semin Thromb Hemost; 1996; 22 Suppl 2():13-8. PubMed ID: 8946614
    [No Abstract]   [Full Text] [Related]  

  • 56.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 57.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 58.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 59.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 60.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.